Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Fulcrum Therapeutics Inc (FULC)

Fulcrum Therapeutics Inc (FULC)
2.62 x 3 3.64 x 1
Post-market by (Cboe BZX)
2.72 +0.21 (+8.37%) 04/07/25 [NASDAQ]
2.62 x 3 3.64 x 1
Post-market 2.72 unch (unch) 16:02 ET
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.32
Day High
2.74
Open 2.46
Previous Close 2.51 2.51
Volume 758,017 758,017
Avg Vol 451,051 451,051
Stochastic %K 17.30% 17.30%
Weighted Alpha -35.88 -35.88
5-Day Change -0.16 (-5.56%) -0.16 (-5.56%)
52-Week Range 2.32 - 10.13 2.32 - 10.13
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 135,487
  • Shares Outstanding, K 53,979
  • Annual Sales, $ 80,000 K
  • Annual Income, $ -9,730 K
  • EBIT $ -30 M
  • EBITDA $ -29 M
  • 60-Month Beta 2.13
  • Price/Sales 1.72
  • Price/Cash Flow N/A
  • Price/Book 0.57

Options Overview Details

View History
  • Implied Volatility 216.02% ( +28.28%)
  • Historical Volatility 73.12%
  • IV Percentile 91%
  • IV Rank 52.29%
  • IV High 403.24% on 02/03/25
  • IV Low 10.81% on 06/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 1,428
  • Open Int (30-Day) 1,761

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.29
  • Number of Estimates 4
  • High Estimate -0.23
  • Low Estimate -0.35
  • Prior Year -0.43
  • Growth Rate Est. (year over year) +32.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.32 +17.24%
on 04/07/25
Period Open: 3.14
3.34 -18.68%
on 03/25/25
-0.42 (-13.38%)
since 03/07/25
3-Month
2.32 +17.24%
on 04/07/25
Period Open: 4.89
4.89 -44.38%
on 01/08/25
-2.17 (-44.38%)
since 01/07/25
52-Week
2.32 +17.24%
on 04/07/25
Period Open: 8.52
10.13 -73.15%
on 08/15/24
-5.80 (-68.08%)
since 04/05/24

Most Recent Stories

More News
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics to Participate in Upcoming December Conferences

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET

FULC : 2.72 (+8.37%)
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FULC : 2.72 (+8.37%)

Business Summary

Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum Therapeutics Inc. is based in Cambridge, United States.

See More

Key Turning Points

3rd Resistance Point 2.75
2nd Resistance Point 2.66
1st Resistance Point 2.58
Last Price 2.72
1st Support Level 2.42
2nd Support Level 2.33
3rd Support Level 2.25

See More

52-Week High 10.13
Fibonacci 61.8% 7.15
Fibonacci 50% 6.22
Fibonacci 38.2% 5.30
Last Price 2.72
52-Week Low 2.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades